Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment
NCT05021536
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
664
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis
Interventions
OTHER:
Placebo
DRUG:
AMX0035
Sponsor
Amylyx Pharmaceuticals Inc.